| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Clover Health Investments, Corp. /de (CLOV) has 12 insiders with recent SEC Form 4 filings, including 4 buys and 9 sells. CLOV is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 9.57M | $29.86M | - | |
| ? | 8.59M | $26.80M | - | |
| CFO | 5.92M | $18.46M | - | |
| CEO | 2.76M | $8.60M | - | |
| CEO | 2.23M | $6.95M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Reynoso Jamie L.63 | CEO, Medicare Advantage | Sell | 2,102 | $2.53 | $5,318.06 | - | -24.0% | - | |
| Dec 18, 2025 | Reynoso Jamie L.63 | CEO, Medicare Advantage | Sell | 4,913 | $2.61 | $12,822.93 | -0.2% | -27.1% | - | |
| Nov 4, 2025 | Reynoso Jamie L.63 | CEO, Medicare Advantage | Sell | 30,385 | $3.58 | $108,778.30 | -1.1% | -37.5% | - | |
| Oct 17, 2025 | Reynoso Jamie L.63 | CEO, Medicare Advantage | Sell | 16,514 | $2.69 | $44,422.66 | -0.6% | -3.3% | - | |
| Oct 7, 2025 | Reynoso Jamie L.63 | CEO, Medicare Advantage | Sell | 2,012 | $2.65 | $5,331.80 | - | -4.1% | - | |
| Sep 17, 2025 | Reynoso Jamie L.63 | CEO, Medicare Advantage | Sell | 4,914 | $3.09 | $15,184.26 | -0.2% | -14.0% | - | |
| Aug 13, 2025 | Loengard Anna U82 | Director | Buy | 26,500 | $2.59 | $68,755.00 | +86.3% | -2.7% | - | |
| Aug 8, 2025 | Garipalli Vivek83 | - | Buy | 446,980 | $2.23 | $998,996.60 | +13.8% | +19.7% | - | |
| Aug 4, 2025 | Reynoso Jamie L.63 | CEO, Medicare Advantage | Sell | 6,823 | $2.89 | $19,718.47 | -0.2% | +27.8% | - | |
| Jul 23, 2025 | Wai Conrad | CEO, Counterpart Health | Sell | 209,797 | $3.30 | $692,968.04 | -6.7% | -5.6% | - |